199 related articles for article (PubMed ID: 11352853)
1. Colonic mucosal prostaglandin E2 and cyclooxygenase expression before and after low aspirin doses in subjects at high risk or at normal risk for colorectal cancer.
Krishnan K; Ruffin MT; Normolle D; Shureiqi I; Burney K; Bailey J; Peters-Golden M; Rock CL; Boland CR; Brenner DE
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):447-53. PubMed ID: 11352853
[TBL] [Abstract][Full Text] [Related]
2. Effect of aspirin on prostaglandin E2 formation and transforming growth factor alpha expression in human rectal mucosa from individuals with a history of adenomatous polyps of the colon.
Barnes CJ; Hamby-Mason RL; Hardman WE; Cameron IL; Speeg KV; Lee M
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):311-5. PubMed ID: 10207634
[TBL] [Abstract][Full Text] [Related]
3. Effects of low-dose aspirin on gastric erosions, cyclooxygenase expression and mucosal prostaglandin-E2 do not depend on Helicobacter pylori infection.
Venerito M; Treiber G; Wex T; Kuester D; Roessner A; Di Mario F; Malfertheiner P
Aliment Pharmacol Ther; 2006 Apr; 23(8):1225-33. PubMed ID: 16611284
[TBL] [Abstract][Full Text] [Related]
4. Effect of subacute ibuprofen dosing on rectal mucosal prostaglandin E2 levels in healthy subjects with a history of resected polyps.
Chow HH; Earnest DL; Clark D; Mason-Liddil N; Kramer CB; Einspahr JG; Guillen-Rodriguez JM; Roe DJ; Malone W; Crowell JA; Alberts DS
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):351-6. PubMed ID: 10794478
[TBL] [Abstract][Full Text] [Related]
5. Effect of aspirin on prostaglandin E2 and leukotriene B4 production in human colonic mucosa from cancer patients.
Frommel TO; Dyavanapalli M; Oldham T; Kazi N; Lietz H; Liao Y; Mobarhan S
Clin Cancer Res; 1997 Feb; 3(2):209-13. PubMed ID: 9815674
[TBL] [Abstract][Full Text] [Related]
6. Short-term/low-dose aspirin-induced duodenal erosions are not dependent on Helicobacter pylori infection, cyclooxygenase expression and prostaglandin E2 levels.
Venerito M; Treiber G; Wex T; Kuester D; Roessner A; Mönkemüller K; Malfertheiner P
Scand J Gastroenterol; 2008; 43(7):801-9. PubMed ID: 18584518
[TBL] [Abstract][Full Text] [Related]
7. Effects of piroxicam on prostaglandin E2 levels in rectal mucosa of adenomatous polyp patients: a randomized phase IIb trial.
Calaluce R; Earnest DL; Heddens D; Einspahr JG; Roe D; Bogert CL; Marshall JR; Alberts DS
Cancer Epidemiol Biomarkers Prev; 2000 Dec; 9(12):1287-92. PubMed ID: 11142413
[TBL] [Abstract][Full Text] [Related]
8. Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-controlled, double-blind randomized trial.
Feldman M; Cryer B; Mallat D; Go MF
Am J Gastroenterol; 2001 Jun; 96(6):1751-7. PubMed ID: 11419825
[TBL] [Abstract][Full Text] [Related]
9. Effects of low dose aspirin (81 mg) on proliferating cell nuclear antigen and Amaranthus caudatus labeling in normal-risk and high-risk human subjects for colorectal cancer.
Krishnan K; Aoki T; Ruffin MT; Normolle DP; Boland CR; Brenner DE
Cancer Detect Prev; 2004; 28(2):107-13. PubMed ID: 15068834
[TBL] [Abstract][Full Text] [Related]
10. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
11. Post-study aspirin intake and factors motivating participation in a colorectal cancer chemoprevention trial.
Sample DA; Sinicrope PS; Wargovich MJ; Sinicrope FA
Cancer Epidemiol Biomarkers Prev; 2002 Mar; 11(3):281-5. PubMed ID: 11895878
[TBL] [Abstract][Full Text] [Related]
12. Clinical development of leukocyte cyclooxygenase 2 activity as a systemic biomarker for cancer chemopreventive agents.
Plummer SM; Hill KA; Festing MF; Steward WP; Gescher AJ; Sharma RA
Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1295-9. PubMed ID: 11751448
[TBL] [Abstract][Full Text] [Related]
13. Platelet activation in patients with colorectal cancer.
Sciulli MG; Filabozzi P; Tacconelli S; Padovano R; Ricciotti E; Capone ML; Grana M; Carnevale V; Patrignani P
Prostaglandins Leukot Essent Fatty Acids; 2005 Feb; 72(2):79-83. PubMed ID: 15626589
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of colorectal cancer - role of gastrin and cyclooxygenase-2.
Hartwich J; Konturek SJ; Pierzchalski P; Zuchowicz M; Konturek PC; Bielański W; Marlicz K; Starzyńska T; Ławniczak M
Med Sci Monit; 2001; 7(6):1171-81. PubMed ID: 11687726
[TBL] [Abstract][Full Text] [Related]
15. Phospholipid association reduces the gastric mucosal toxicity of aspirin in human subjects.
Anand BS; Romero JJ; Sanduja SK; Lichtenberger LM
Am J Gastroenterol; 1999 Jul; 94(7):1818-22. PubMed ID: 10406241
[TBL] [Abstract][Full Text] [Related]
16. Subepithelial myofibroblasts express cyclooxygenase-2 in colorectal tubular adenomas.
Adegboyega PA; Ololade O; Saada J; Mifflin R; Di Mari JF; Powell DW
Clin Cancer Res; 2004 Sep; 10(17):5870-9. PubMed ID: 15355919
[TBL] [Abstract][Full Text] [Related]
17. Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences.
Garcea G; Berry DP; Jones DJ; Singh R; Dennison AR; Farmer PB; Sharma RA; Steward WP; Gescher AJ
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):120-5. PubMed ID: 15668484
[TBL] [Abstract][Full Text] [Related]
18. Comparisons of the anti-proliferative effects of butyrate and aspirin on human colonic mucosa in vitro.
Gostner A; Dusel G; Kelber E; Scheppach W; Bartram HP
Eur J Cancer Prev; 2000 Jun; 9(3):205-11. PubMed ID: 10954260
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer.
Kulke MH; Odze RD; Mueller JD; Wang H; Redston M; Bertagnolli MM
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1579-86. PubMed ID: 15173710
[TBL] [Abstract][Full Text] [Related]
20. Colon cancer chemoprevention: clinical development of aspirin as a chemopreventive agent.
Krishnan K; Ruffin MT; Brenner DE
J Cell Biochem Suppl; 1997; 28-29():148-58. PubMed ID: 9589361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]